Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8®
RZOLV Reports Approximately 97.0% Gold Recovery on Complex Copper-Gold Ore Without Pretreatment, Highlighting Potential to Simplify Flowsheets Versus Cyanide
RZOLV Reports Approximately 97.0% Gold Recovery on Complex Copper-Gold Ore Without Pretreatment, Highlighting Potential to Simplify Flowsheets Versus Cyanide